Announcements Trials
Browse Landscape

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1Other hematologic neoplasm 1Myeloid 1

Conditions

Neoplasms 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Hypertension, Pulmonary 1

Interventions

Surveys and Questionnaires 529Blood Specimen Collection 406Surgical Procedures, Operative 152Radiotherapy 131Interviews as Topic 131Drug Therapy 123Observation 122Magnetic Resonance Spectroscopy 104Biopsy 103Specimen Handling 70Data Collection 70Neoadjuvant Therapy 65Immunohistochemistry 64Magnetic Resonance Imaging 61Immune Checkpoint Inhibitors 59Watchful Waiting 52Immunotherapy 51Bevacizumab 50Positron Emission Tomography Computed Tomography 46Ultrasonography 44Hematologic Tests 42Liquid Biopsy 41Tomography, X-Ray Computed 40Therapeutics 40Radiosurgery 40Colonoscopy 40pembrolizumab 37Hepatectomy 37Gene Expression Profiling 36High-Energy Shock Waves 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Observational × Caves × Clear all
NCT04036045 2025-10-06

Approaches to Identify Early Biomarkers and Pathogenesis of Anthracycline Cardiotoxicity

Connecticut Children's Medical Center

Withdrawn
Tumor-Agnostic

Neoplasms

NCT01805843 2015-09-09

Pulmonary Vasculopathy Under Second-line Therapy of Chronic Myeloid Leukemia

Medical University of Graz

Completed
16 enrolled
MyeloidOther hematologic neoplasm

Hypertension, Pulmonary, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡